← Leaderboards
Todd A Waldman
Georgetown University
$8,346,833
Attributed
$10,202,148
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $885.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,202,148 · 10
By mechanism
R01$8,786,230 · 5
K01$722,304 · 1
R21$361,239 · 1
R03$232,375 · 2
R55$100,000 · 1
Top collaborators
- Charles David James5 shared
- Fulai Jin4 shared
Most similar at Georgetown University
Same institution · by research overlap
- Kevin J Cullen$20,041,785
- Anatoly Dritschilo$2,524,432
- Jeanne Mandelblatt$29,742,067
- Vicente Notario$4,836,458
- Arnold L Potosky$11,589,176
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsTumor Suppressor GenesMutationCell LineGene TargetingGenesTumorIn VitroDna DamageCancer CellGrantGlioblastomaNormal CellBaseResearch PersonnelPathogenesisGeneticOncogenesMutantProteinsBiological ModelsPlayComplex
Grant awards (41)
STAG2 mutations and 3D genome organization in glioblastoma multiforme$535,445
R01 · FY2025 · CA · contact PI
STAG2 mutations and 3D genome organization in glioblastoma multiforme$508,673
R01 · FY2024 · CA · contact PI
STAG2 mutations and 3D genome organization in glioblastoma multiforme$524,737
R01 · FY2023 · CA · contact PI
STAG2 mutations and 3D genome organization in glioblastoma multiforme$549,445
R01 · FY2022 · CA · contact PI
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer$322,663
R01 · FY2017 · CA · contact PI
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer$322,663
R01 · FY2016 · CA · contact PI
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme$321,625
R01 · FY2016 · CA · contact PI
A PTEN-dependent cell size checkpoint in human cells$241,207
R01 · FY2016 · CA · contact PI
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer$322,663
R01 · FY2015 · CA · contact PI
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme$321,625
R01 · FY2015 · CA · contact PI
A PTEN-dependent cell size checkpoint in human cells$241,207
R01 · FY2015 · CA · contact PI
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer$312,983
R01 · FY2014 · CA · contact PI
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme$311,977
R01 · FY2014 · CA · contact PI
A PTEN-dependent cell size checkpoint in human cells$233,970
R01 · FY2014 · CA · contact PI
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer$322,317
R01 · FY2013 · CA · contact PI
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme$302,246
R01 · FY2013 · CA · contact PI
A PTEN-dependent cell size checkpoint in human cells$241,207
R01 · FY2013 · CA · contact PI
Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme$334,857
R01 · FY2012 · CA · contact PI
Development and Application of Endogenous Epitope Tagging Technology in Human Cel$194,308
R21 · FY2011 · CA · contact PI
A PTEN-Dependent Size Checkpoint in Human Cancer Cells$240,742
R01 · FY2010 · CA · contact PI
Development and Application of Endogenous Epitope Tagging Technology in Human Cel$166,931
R21 · FY2010 · CA · contact PI
A PTEN-Dependent Size Checkpoint in Human Cancer Cells$180,099
R01 · FY2009 · CA · contact PI
A PTEN-Dependent Size Checkpoint in Human Cancer Cells$240,742
R01 · FY2008 · CA · contact PI
A PTEN-Dependent Size Checkpoint in Human Cancer Cells$60,643
R01 · FY2008 · CA · contact PI
Isogenic Cell-Based Screen:Cancer-Targeting Catenin(RMI)$38,375
R03 · FY2008 · NS · contact PI
Genetic Analysis of Beta-Catenin Function in Human CA$260,660
R01 · FY2007 · CA · contact PI
A PTEN-Dependent Size Checkpoint in Human Cancer Cells$240,742
R01 · FY2007 · CA · contact PI
Isogenic Cell-Based Screen:Cancer-Targeting Catenin(RMI)$38,800
R03 · FY2007 · NS · contact PI
Genetic Analysis of Beta-Catenin Function in Human CA$268,445
R01 · FY2006 · CA · contact PI
A PTEN-Dependent Size Checkpoint in Human Cancer Cells$247,932
R01 · FY2006 · CA · contact PI
Genetic Analysis of Beta-Catenin Function in Human CA$274,905
R01 · FY2005 · CA
Isogenic Cell-Based Screen:Cancer-Targeting Catenin(RMI)$77,600
R03 · FY2005 · NS
Genetic Analysis of Beta-Catenin Function in Human CA$274,905
R01 · FY2004 · CA
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION$154,440
K01 · FY2004 · CA
Cell-Based Screens for Cancer:Targeting PTEN (RMI)$77,600
R03 · FY2004 · NS
Genetic Analysis of Beta-Catenin Function in Human CA$224,905
R01 · FY2003 · CA
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION$154,440
K01 · FY2003 · CA
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION$154,440
K01 · FY2002 · CA
Genetic Analysis of B-Catenin Function in Human Cancer$100,000
R55 · FY2002 · CA
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION$132,840
K01 · FY2001 · CA
GENETIC ANALYSIS OF TUMOR SUPPRESSOR GENE FUNCTION$126,144
K01 · FY2000 · CA